Octanoic acid prevents reduction of striatal dopamine in the MPTP mouse model of Parkinson’s disease

被引:2
|
作者
Ilona Joniec-Maciejak
Adriana Wawer
Danuta Turzyńska
Alicja Sobolewska
Piotr Maciejak
Janusz Szyndler
Dagmara Mirowska-Guzel
Adam Płaźnik
机构
[1] Medical University of Warsaw,Department of Experimental and Clinical Pharmacology
[2] Centre for Preclinical Research and Technology (CePT),Department of Neurochemistry
[3] Institute of Psychiatry and Neurology,undefined
来源
Pharmacological Reports | 2018年 / 70卷
关键词
Parkinson’s disease; Octanoic acid; MPTP; PGC-1α; PEPCK;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:988 / 992
页数:4
相关论文
共 50 条
  • [21] TLR3 contributes to degeneration of dopamine neurons in an MPTP mouse model of Parkinson's disease
    Chung, Young Cheul
    Jeong, Jaeyeong
    Jin, Byung Kwan
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [22] An Angiogenic Inhibitor Reduces Dopamine Neuron Loss and Neuroinflammation in an MPTP Mouse Model of Parkinson's Disease
    Patel, A.
    Desai, B.
    Carvey, P. M.
    Hendey, B.
    CELL TRANSPLANTATION, 2010, 19 (03) : 356 - 356
  • [23] Capsaicin prevents degeneration of dopamine neurons by inhibiting glial activation and oxidative stress in the MPTP model of Parkinson's disease
    Chung, Young C.
    Baek, Jeong Y.
    Kim, Sang R.
    Ko, Hyuk W.
    Bok, Eugene
    Shin, Won-Ho
    Won, So-Yoon
    Jin, Byung K.
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2017, 49 : e298 - e298
  • [24] Cinnamic acid protects the nigrostriatum in MPTP mouse model of Parkinson's disease via the PPARα
    Prorok, Tim
    Pahan, Kalipada
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2018, 13 : S68 - S69
  • [25] Capsaicin prevents degeneration of dopamine neurons by inhibiting glial activation and oxidative stress in the MPTP model of Parkinson’s disease
    Young C Chung
    Jeong Y Baek
    Sang R Kim
    Hyuk W Ko
    Eugene Bok
    Won-Ho Shin
    So-Yoon Won
    Byung K Jin
    Experimental & Molecular Medicine, 2017, 49 : e298 - e298
  • [26] Cinnamic acid protects the nigrostriatum in MPTP mouse model of Parkinson's disease via the PPARα
    Prorok, Tim
    Pahan, Kalipada
    JOURNAL OF NEUROVIROLOGY, 2018, 24 : S68 - S69
  • [27] Effect of valerenic acid on neuroinflammation in a MPTP-induced mouse model of Parkinson's disease
    Rodriguez-Cruz, Alfredo
    Romo-Mancillas, Antonio
    Mendiola-Precoma, Jesus
    Esther Escobar-Cabrera, Jesica
    Garcia-Alcocer, Guadalupe
    Cristina Berumen, Laura
    IBRO REPORTS, 2020, 8 : 28 - 35
  • [28] Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease
    Andringa, G
    Drukarch, B
    Bol, JGJM
    de Bruin, K
    Sorman, K
    Habraken, JBA
    Booij, J
    NEUROIMAGE, 2005, 26 (04) : 1150 - 1158
  • [29] Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease
    Du, YS
    Ma, ZZ
    Lin, SZ
    Dodel, RC
    Gao, F
    Bales, KR
    Triarhou, LC
    Chernet, E
    Perry, KW
    Nelson, DLG
    Luecke, S
    Phebus, LA
    Bymaster, FP
    Paul, SM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (25) : 14669 - 14674
  • [30] The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease
    Litim, Nadhir
    Bourque, Melanie
    Al Sweidi, Sara
    Morissette, Marc
    Di Paolo, Therese
    NEUROPHARMACOLOGY, 2015, 97 : 86 - 94